Mini Review - (2015) Volume 7, Issue 3

Prenatal Exposures to Environmental Agents or Drugs Promote the Development of Diseases Later in Life

Andrei N. Tchernitchin* and Leonardo Gaete
Laboratory of Experimental Endocrinology and Environmental Pathology, ICBM, University of Chile, Medical School, and Environmental Department, Chilean Medical College, Chile
*Corresponding Author: Andrei N. Tchernitchin, Laboratory of Experimental Endocrinology and Environmental Pathology, ICBM, University of Chile, Medical School, And Environmental Department, Chilean Medical College, Chile, Tel: 562-297-862-22 Email:


Prenatal or early postnatal exposure to several agents displaying hormonal action causes persistent quantitative and qualitative changes in hormone receptors in various cell-types. Exposure must occur during the windows of susceptibility, which occurs at specific times for each cell-type and hormone receptor. These alterations, that persist through life, are induced by the mechanism of epigenetic imprinting (cell programming). Studies performed in our Labs and elsewhere found that not only hormones or agents displaying hormone action, but also those not displaying this activity, may induce the mechanism of imprinting; among them, lead and arsenic

Keywords: Prenatal exposures; Lead; Arsenic; Dioxins; Epigenomic imprinting

Background and Methodology

The present mini-review describes the delayed effects of prenatal exposure to the most conspicuous environmental agents reported to increase several diseases risk later in life. The chosen agents are examples of a wide mechanism involving numerous agents, to which physicians and other health professionals should pay attention. Examples of less known food pollutants or drugs are also presented.

Selected agents were chosen based on the best known mechanistic and toxicological characteristics and also on most clinically relevant adverse effects on human health. Less relevant effects were excluded.

Searches were performed through Pubmed/Medline, ISI, and other sources, without date restrictions. References were selected considering the finding first report, and the most detailed description.

Overview of Prenatal Exposure and the Mechanisms of Epigenomic Imprinting

Prenatal or early postnatal exposure to several agents displaying hormonal action causes persistent quantitative and qualitative changes in hormone receptors in various cell-types [1]. Exposure must occur during the windows of susceptibility, which occurs at specific times for each cell-type and hormone receptor. These alterations, that persist through life, are induced by the mechanism of epigenetic imprinting (cell programming) [2,3]. Studies performed in our Labs [2-5] and elsewhere found that not only hormones or agents displaying hormone action, but also those not displaying this activity, may induce the mechanism of imprinting; among them, lead and arsenic. Imprinting-inducing agents may be found among environmental pollutants, pharmaceuticals, drugs of abuse, food additives and anthropogenic or natural compounds present in food [4-6]. It was proposed that changes induced by the mechanism of imprinting are the root for the development of various diseases and neurobehavioral changes later in life [5,6]. For humans, the first evidence that prenatal exposure to a pharmaceutical agent (the synthetic estrogen diethylstilbestrol) induces imprinting emerged from clear cell cervicovaginal adenocarcinoma development in young women whose mothers received treatment with diethylstilbestrol during pregnancy [7]. Prenatal exposure to the same agent induced the development of similar tumors in experimental animals [8], induced an increase in uterine estrogen receptors [1] and caused a great potentiation of a response to estrogen in a uterine cell-type [9] at older ages.

Knowledge of the etiology of the different diseases aims to the development of protective measures to decrease their incidence and to find new therapeutic approaches. Genomic characterization is important to analyze the risk for various pathologies, such as cancer, autoimmune diseases, neurodegenerative pathologies. However, somatic cells genome may be permanently altered by epigenetic changes through methylation and demetylation processes thus modifying the susceptibility to develop these diseases. For instance, methylation changes were reported in brain of patients affected with various Parkinson [10], Alzheimer [11] and Huntington [12] diseases and probably multiple sclerosis [13,14]. Several conditions during gestation may modulate brain development, such as maternal diet, stress and diseases (diabetes, hypertension), or maternal treatment with pharmaceuticals. The above epigenetic factors may affect brain cell programming and they may condition susceptibility or resistance for the development of various neurodegenerative diseases [15].

The best known imprinters from the environmental pollutants are lead, arsenic, cadmium, benzopyrene and various dioxins, furans, polychlorinated biphenyls and pesticides (DDT, DDE, methoxychlor, chlordecone, parathion, malathion, paraquat, cypermethrin and cyhalothrin). Among drugs, diethylstilbestrol, anti-epileptic drugs, and neuroleptic agents binding barbiturate or benzodiazepine receptors. Drugs of abuse such as cocaine, opiates, ketamine, toluene, tetrahydrocannabinol, ethanol and tobacco smoking. Food additives: nitrites, caffeine, aspartame, etc. Other agents found in food include bisphenol-A, nonylphenol, phthalates, acrylamide and steroids used as farm animal growth promoters. High prenatal lipid feeding induces cholesterol homeostatic memory [16] and alters blood estrogen levels during adulthood, which is a risk factor for breast cancer [17]. Therefore dietary factors in early life determine the prevalence of various diseases in adulthood.

Below we describe examples of some of the delayed adverse effects of early exposure to the most known imprinters: lead, arsenic, dioxins, antiepileptic drugs and bisphenol-A.

Prenatal exposure to lead

In prepubertal rats, prenatal exposure to lead potentiates two non-genomic responses to estrogen, while in the absence of prenatal exposure, lead inhibits these responses [4]. This finding led us to propose that epigenetic imprinting is a mechanism that developed some time in the evolution and allowed species survival under unfavorable environmental conditions since it provided protection neutralizing adverse effects of chronic exposure to lead and perhaps other agents [4,5].

In addition to early developmental lead exposure which contributes to fertility inhibition in humans and experimental animals [18], the most relevant effects of early lead exposure are those affecting central nervous system. Several neurological and neurobehavioral changes attributed to lead exposure were reported in countries with high lead pollution levels [19-21]. It causes learning impairment, lower IQ scores, increased school failure [22,23]. A deficit in the IQ scores was detected in children with lead blood levels of 9 µg/dL [21]; IQ declined by 7.4 points as lifetime average blood lead concentrations increased from 1 to 10 µg/dL [24]. Blood lead levels from 5 to 9 μg/dL increased in the percentage of students requiring special education [25]. Perinatal or infant human lead exposure causes the development of a hyperactive and aggressive behavior [19]; lead content in tibia at the age of 12 years, was associated to increased risk for antisocial and delinquent behavior [26]. Data on year lead amounts used in different countries revealed an association with crime indexes. Despite divergent international crime trends, regression R2 is near its peak in each nation (in USA, Australia, France, Italy, West Germany, Britain, New Zealand, Canada and Finland) with a lag of 19 years [27]. Following prenatal exposure to lead, a permanent increase in the affinity of δ-opioid receptors [28] was reported in the rat brain. This finding lead us to hypothesize that early exposure to lead may facilitate addiction to drugs of abuse (opiates and stimulants) in countries with high lead pollution [2]. This hypothesis was confirmed in experimental animals by studies of other authors [29-33].

Prenatal exposure to arsenic

Arsenic prenatal exposure affects respiratory functions later in life. Drinking water in the Chilean city of Antofagasta had very high arsenic levels between 1958 and 1970 (around 0.8 mg/L). Antofagasta mortality rates in the period 1989-2000 were compared with the rest of Chile, focusing on subjects born during or just before the peak exposure period and who were 30-49 years old at the time of death (prenatally exposed). They were compared to the cohort born before the high-exposure period (1950-1957) and exposed in childhood later but not prenatally. Standard mortality ratio for bronchiectasis in prenatally exposed population was four times higher than in non prenatally exposed [34].

Prenatal exposure to polychlorinated biphenyl/dioxins

Polychlorinated biphenyl/dioxin prenatal exposure imprints changes in the immune system, central nervous system and mainly male reproductive system in humans. It is associated with total number of T cells and the number of CD8+ (cytotoxic), TcRαβ+, and TcRγδ+ T cells increase in infants [35], and immune depression that persists through childhood, in prenatally exposed children [36]. A decrease in lung function was also associated with perinatal exposure to background levels of dioxins [37]. Prenatal exposure to polychlorinated biphenyls and dibenzofuranes determine, at young adult age, persistent alterations in sperm quality and inhibits spermatozoid capacity to penetrate hamster oocytes; therefore, it may cause male infertility [38]. Prenatal exposure to dioxins, furans or polychlorinated biphenyls was reported to determine feminization of 7-8 year old male children gender-related play behavior [39]. In experimental animals, it was shown that prenatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin also determines demasculinization and feminization of sex behavior in male rats [40,41], which was not associated with alterations in estrogen receptor binding or sexually differentiated brain nuclei volumes [41]. Permanent morphologic and behavior male demasculinization, feminization, and decrease in fertility were also reported in rats and hamsters following prenatal exposure to dioxin [42].

Examples of prenatal exposure to drugs or food pollutants

Prenatal exposure to some antiepileptic drugs increases the risk of behavioral problems in preschool children [43]. Bisphenol-A prenatal or neonatal exposure of experimental animals was associated to advancement of puberty and affected sexual dimorphic hypothalamic areas by increasing oxytocin immunoreactive neurons [44], development of several ovary and uterine pathologies [45] and early adipogenesis [46].

Concluding Remarks

The chosen selected examples of pollutants and drugs to which human population is exposed should alert countries governments to endorse stricter standards and tighten legislation to protect future generations from diseases that may develop following prenatal or early infant exposures. While imprinting may be a positive mechanism to preserve species through evolution, prenatal exposure to pollutants or drugs in human population clearly increase the risk for several diseases. We also alert scientific communities on probable effects of many additional agents that had not been yet investigated for its potential epigenetic imprinting.


  1. Csaba G, Inczefi-Gonda A, Dobozy O (1986) Hormonal imprinting by steroids: a single neonatal treatment with diethylstilbestrol or allylestrenol gives rise to a lasting decrease in the number of rat uterine receptors. Acta Physiol Hung 67: 207-212.
  2. Tchernitchin AN, Tchernitchin N (1992) Imprinting of paths of heterodifferentiation by prenatal or neonatal exposure to hormones, pharmaceuticals, pollutants and other agents or conditions. Med Sci Res 20: 391-397.
  3. Tchernitchin AN, Tchernitchin NN, Mena MA, Unda C, Soto J (1999) Imprinting: perinatal exposures cause the development of diseases during the adult age. Acta Biol Hung 50: 425-440.
  4. Tchernitchin AN, Gaete L, Bustamante R, Báez A (2011) Effect of prenatal exposure to lead on estrogen action in the prepubertal rat uterus. ISRN Obstet Gynecol 2011: 329692.
  5. Tchernitchin AN, Gaete L, Bustamante R, Sorokin YA (2013) Adulthood prenatally programmed diseases – Health relevance and methods of study. In: Protein Purification and Analysis I. Methods and Applications. iConcept Press, Hong Kong, 217-258.
  6. Tchernitchin AN (2005) Perinatal exposure to chemical agents: delayed effects by the mechanism of imprinting (cell program-ming). ARBS Ann Rev Biomed Sci 7: 68-126.
  7. Herbst AL (1981) Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 48: 484-488.
  8. Walker BE (1983) Uterine tumors in old female mice exposed prenatally to diethylstilbestrol. J Natl Cancer Inst 70: 477-484.
  9. Tchernitchin AN, Mena MA (2006) Efectos diferidos de contaminantes ambientales y otros agentes en salud reproductiva y sexualidad: un desafío pendiente de la toxicología de la reproducción para la salud de las futuras generaciones. Cuad Méd Soc (Chile) 46: 176-194.
  10. Masliah E, Dumaop W, Galasko D (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Landes Biosci. 8: 1030-1038.
  11. van den Hove DL, Chouliaras L, Rutten BP (2012) The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies. Curr Alzheimer Res 9: 545-549.
  12. Wang F, Yang Y, Lin X, Wang JQ, Wu YS, et al. (2013) Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum Mol Genet 22: 3641-3653.
  13. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, et al. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45: 1353-1360.
  14. Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, et al. (2014) TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells. Biochim Biophys Acta 1842: 1130-1136.
  15. Faa G, Marcialis MA, Ravarino A, Piras M, Pintus MC, et al. (2014) Fetal programming of the human brain: is there a link with insurgence of neurodegenerative disorders in adulthood? Curr Med Chem 21: 3854-3876.
  16. Brown SA, Rogers LK, Dunn JK, Gotto AM Jr, Patsch W (1990) Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. Metabolism 39: 468-473.
  17. Hilakivi-Clarke L, Clarke R, Lippman ME (1994) Perinatal factors increase breast cancer risk. Breast Cancer Res Treat 31: 273-284.
  18. Winder C (1993) Lead, reproduction and development. Neurotoxicology 14: 303-317.
  19. Tchernitchin AN, Lapin N, Molina L, Molina G, Tchernitchin NA, et al. (2005) Human exposure to lead in Chile. Rev Environ Contam Toxicol 185: 93-139.
  20. Donaldson SG, Van Oostdam J, Tikhonov C, Feeley M, Armstrong B, et al. (2010) Environmental contaminants and human health in the Canadian Arctic. Sci Total Environ 408: 5165-5234.
  21. Mielke HW, Laidlaw MA, Gonzales CR (2011) Estimation of leaded (Pb) gasoline's continuing material and health impacts on 90 US urbanized areas. Environ Int 37: 248-257.
  22. Rothenberg SJ, Schnaas L, Cansino-Ortiz S, Perroni-Hernández E, de la Torre P, et al. (1989) Neurobehavioral deficits after low level lead exposure in neonates: the Mexico City pilot study. Neurotoxicol Teratol 11: 85-93.
  23. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN (1990) The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med 322: 83-88.
  24. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, et al. (2003) Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348: 1517-1526.
  25. Tarr H, Raymond RE, Tufts M (2009) The effects of lead exposure on school outcome among children living and attending public schools in Detroit.
  26. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB (1996) Bone lead levels and delinquent behavior. JAMA 275: 363-369.
  27. Nevin R (2007) Understanding international crime trends: the legacy of preschool lead exposure. Environ Res 104: 315-336.
  28. McDowell J, Kitchen I (1988) Perinatal lead exposure alters the development of delta- but not mu-opioid receptors in rat brain. Br J Pharmacol 94: 933-937.
  29. Kitchen I, Kelly M (1993) Effect of perinatal lead treatment on morphine dependence in the adult rat. Neurotoxicology 14: 125-129.
  30. Rocha A, Valles R, Cardon AL, Bratton GR, Nation JR (2005) Enhanced acquisition of cocaine self-administration in rats developmentally exposed to lead. Neuropsychopharmacology 30: 2058-2064.
  31. Nation JR, Miller DK, Bratton GR (2000) Developmental lead exposure alters the stimulatory properties of cocaine at PND 30 and PND 90 in the rat. Neuropsychopharmacology 23: 444-454.
  32. Nation JR, Cardon AL, Heard HM, Valles R, Bratton GR (2003) Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinstatement study. Psychopharmacology 168: 236-243.
  33. Nation JR, Smith KR, Bratton GR (2004) Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm. Pharmacol Biochem Behav 77: 127-135.
  34. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, et al. (2006) Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114: 1293-1296.
  35. Weisglas-Kuperus N, Sas TC, Koopman-Esseboom C, van der Zwan CW, De Ridder MA, et al. (1995) Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediat Res 38: 404-410.
  36. Weisglas-Kuperus N, Vreugdenhil HJ, Mulder PG (2004). Immunological effects of environmental exposure to polychlorinated biphenyls and dioxins in Dutch school children. Toxicol Lett 149: 281-285.
  37. ten Tusscher GW, de Weerdt J, Roos CM, Griffioen RW, De Jongh FH, et al. (2001) Decreased lung function associated with perinatal exposure to Dutch background levels of dioxins. Acta Paediatr 90: 1292-1298.
  38. Guo YL, Hsu PC, Hsu CC, Lambert GH (2000) Semen quality after prenatal exposure to polychlorinated biphenyls and dibenzofurans. Lancet 356: 1240-1241.
  39. Vreugdenhil HJ, Slijper FM, Mulder PG, Weisglas-Kuperus N (2002) Effects of perinatal exposure to PCBs and dioxins on play behavior in Dutch children at school age. Environ Health Perspect 110: A593-598.
  40. Mably TA, Moore RW, Goy RW, Peterson RE (1992) In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Effects on sexual behavior and the regulation of luteinizing hormone secretion in adulthood. Toxicol Appl Pharmacol 114: 108-117.
  41. Bjerke DL, Brown TJ, MacLusky NJ, Hochberg RB, Peterson RE (1994) Partial demasculinization and feminization of sex behavior in male rats by in utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin is not associated with alterations in estrogen receptor binding or volumes of sexually differentiated brain nuclei. Toxicol Appl Pharmacol 127: 258-267.
  42. Gray LE Jr, Kelce WR, Monosson E, Ostby JS, Birnbaum LS (1995) Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol 131: 108-118.
  43. Kjaer D, Christensen J, Bech BH, Pedersen LH, Vestergaard M, et al. (2013) Preschool behavioral problems in children prenatally exposed to antiepileptic drugs - a follow-up study. Epilepsy Behav 29: 407-411.
  44. Adewale HB, Todd KL, Mickens JA, Patisaul HB (2011) The impact of neonatal bisphenol-A exposure on sexually dimorphic hypothalamic nuclei in the female rat. Neurotoxicology 32: 38-49.
  45. Newbold RR, Jefferson WN, Padilla-Banks E (2007) Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24: 253-258.
  46. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, et al. (2009) Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 117: 1549-1555.
Citation: Tchernitchin and Gaete (2015) Prenatal Exposures to Environmental Agents or Drugs Promote the Development of Diseases Later in Life. Biol Med (Aligarh) 7: 236.

Copyright: © 2015 Tchernitchin, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.